{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:25:35Z","timestamp":1788963935381,"version":"build-2803163510"},"reference-count":26,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:00:00Z","timestamp":1570838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["15-34553A"],"award-info":[{"award-number":["15-34553A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Central nervous system (CNS) malignancies include primary tumors that originate within the CNS as well as secondary tumors that develop as a result of metastatic spread. Circulating microRNAs (miRNAs) were found in almost all human body fluids including cerebrospinal fluid (CSF), and they seem to be highly stable and resistant to even extreme conditions. The overall aim of our study was to identify specific CSF miRNA patterns that could differentiate among brain tumors. These new biomarkers could potentially aid borderline or uncertain imaging results onto diagnosis of CNS malignancies, avoiding most invasive procedures such as stereotactic biopsy or biopsy. In total, 175 brain tumor patients (glioblastomas, low-grade gliomas, meningiomas and brain metastases), and 40 non-tumor patients with hydrocephalus as controls were included in this prospective monocentric study. Firstly, we performed high-throughput miRNA profiling (Illumina small RNA sequencing) on a discovery cohort of 70 patients and 19 controls and identified specific miRNA signatures of all brain tumor types tested. Secondly, validation of 9 candidate miRNAs was carried out on an independent cohort of 105 brain tumor patients and 21 controls using qRT-PCR. Based on the successful results of validation and various combination patterns of only 5 miRNA levels (miR-30e, miR-140, let-7b, mR-10a and miR-21-3p) we proposed CSF-diagnostic scores for each tumor type which enabled to distinguish them from healthy donors and other tumor types tested. In addition to this primary diagnostic tool, we described the prognostic potential of the combination of miR-10b and miR-196b levels in CSF of glioblastoma patients. In conclusion, we performed the largest study so far focused on CSF miRNA profiling in patients with brain tumors, and we believe that this new class of biomarkers have a strong potential as a diagnostic and prognostic tool in these patients.<\/jats:p>","DOI":"10.3390\/cancers11101546","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T03:54:13Z","timestamp":1571025253000},"page":"1546","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors"],"prefix":"10.3390","volume":"11","author":[{"given":"Alena","family":"Kopkova","sequence":"first","affiliation":[{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Sana","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno 625 00, Czech Republic"},{"name":"Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno 656 53, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tana","family":"Machackova","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7510-3694","authenticated-orcid":false,"given":"Marek","family":"Vecera","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Radova","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Trachtova","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaclav","family":"Vybihal","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Brno, Brno 625 00, Czech Republic"},{"name":"Faculty of Medicine, Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Smrcka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Brno, Brno 625 00, Czech Republic"},{"name":"Faculty of Medicine, Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7288-8975","authenticated-orcid":false,"given":"Tomas","family":"Kazda","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Masaryk University, Brno 625 00, Czech Republic"},{"name":"Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno 656 53, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Slaby","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno 625 00, Czech Republic"},{"name":"Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno 656 53, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Fadrus","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Brno, Brno 625 00, Czech Republic"},{"name":"Faculty of Medicine, Masaryk University, Brno 625 00, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/neuonc\/nou283","article-title":"The worldwide incidence and prevalence of primary brain tumors: A systematic review and meta-analysis","volume":"17","author":"Fiest","year":"2015","journal-title":"Neuro. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"ref_3","first-page":"29","article-title":"Molecular biology of gliomas: Present and future challenges","volume":"10","author":"Altieri","year":"2014","journal-title":"Transl. Med. UniSa"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/neuonc\/nov022","article-title":"Response to \u201cthe epidemiology of glioma in adults: A \u2018state of the science\u2019 review\u201d","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: A multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1470-2045(17)30153-5","article-title":"Epigenetics: A new tool for meningioma management?","volume":"18","author":"Sanson","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Shaikh, N., Dixit, K., and Raizer, J. (2018). Recent advances in managing\/understanding meningioma. F1000Research, 7.","DOI":"10.12688\/f1000research.13674.1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0030-1255225","article-title":"Brain metastases","volume":"30","author":"Kamar","year":"2010","journal-title":"Semin. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1515\/cclm-2017-0958","article-title":"Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors","volume":"56","author":"Kopkova","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"29103","DOI":"10.3390\/ijms161226150","article-title":"Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies","volume":"16","author":"Shalaby","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/j.1582-4934.2011.01317.x","article-title":"MicroRNAs and glioblastoma: Roles in core signalling pathways and potential clinical implications","volume":"15","author":"Sana","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nor169","article-title":"Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma","volume":"14","author":"Baraniskin","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/neuonc\/nos074","article-title":"MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity","volume":"14","author":"Teplyuk","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20829","DOI":"10.18632\/oncotarget.4096","article-title":"A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies","volume":"6","author":"Drusco","year":"2015","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrg2634","article-title":"Causes and consequences of microRNA dysregulation in cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2050-7771-2-19","article-title":"MicroRNAs as promising biomarkers in cancer diagnostics","volume":"2","author":"Mishra","year":"2014","journal-title":"Biomark. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"33994","DOI":"10.18632\/oncotarget.9188","article-title":"Extracellular mirna-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations","volume":"7","author":"Qu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13046-016-0393-0","article-title":"A restricted signature of serum mirnas distinguishes glioblastoma from lower grade gliomas","volume":"35","author":"Regazzo","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/1078-0432.CCR-10-0207","article-title":"Mirna-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance","volume":"16","author":"Guan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_21","first-page":"6576","article-title":"High mir-196a and low mir-367 cooperatively correlate with unfavorable prognosis of high-grade glioma","volume":"8","author":"Guan","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.18632\/oncotarget.2679","article-title":"Microrna expression patterns in the malignant progression of gliomas and a 5-microrna signature for prognosis","volume":"5","author":"Yan","year":"2014","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.molonc.2013.12.010","article-title":"Expression of 19 micrornas in glioblastoma and comparison with other brain neoplasia of grades i-iii","volume":"8","author":"Visani","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e15784","DOI":"10.1097\/MD.0000000000015784","article-title":"Decreased let-7b is associated with poor prognosis in glioma","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1750-3639.2009.00328.x","article-title":"Identification and functional characterization of micrornas involved in the malignant progression of gliomas","volume":"20","author":"Malzkorn","year":"2010","journal-title":"Brain Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kopkova, A., Sana, J., Fadrus, P., Machackova, T., Vecera, M., Vybihal, V., Juracek, J., Vychytilova-Faltejskova, P., Smrcka, M., and Slaby, O. (2018). MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208580"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/10\/1546\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:47Z","timestamp":1760189147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/10\/1546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,12]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["cancers11101546"],"URL":"https:\/\/doi.org\/10.3390\/cancers11101546","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,12]]}}}